Prescription Services Research Articles

The Causes of Long Waiting Times for Outpatient Pharmaceutical Prescription Services at Hospital “X” in Padang

Outpatient pharmacy services in a hospital shows the quality of health service to the community. Data from the internal quality assurance report of Hospital ”X” in Padang showed that only 93.76% of non-compounded medication and 94.6% of compounded medication recipes met the waiting time standard. This study aimed to analyze the causes of the long waiting time for outpatient pharmacy services at Hospital “X”. The type of this research was a mix-method sequential type explanatory, conducted from February until May 2022. The quantitative design was a cross-sectional study of 141 for non-concoction and 35 for compounded medication recipes determined by quota sampling. Qualitative research was conducted on seven informants by purposive sampling. Observation, in-depth interviews, and document review collected data. Results showed that the average waiting time was 84.19 (standard ≤30) minutes for non-concoction and 164.58 (standard ≤60) minutes for compounded medication recipes. The causes of the long waiting time were a need for more staff, prescriptions outside the hospital formulary, equipment errors, and medicines delivery delays. There should be a job redesign by rearranging the shift picket for pharmacy staff, regular equipment maintenance, and updating standard operating procedures related to medicines delivery to the patients.

Patient and family perceptions of the provision of medicines as part of virtual outpatient consultations for children during COVID-19 pandemic

ObjectivesTo evaluate (1) views and perceptions of patients/parents/carers and healthcare professionals on the medicines optimisation (MO) process following virtual outpatient clinic (VOC) during the COVID-19 pandemic and (2) the processes...

Evaluating the impact of clinical screening by a hospital pharmacy team on the homecare prescription service

Abstract Introduction The homecare prescription service delivers medicines initiated by hospital prescribers directly to patients. The Trust utilises homecare services for approximately 4,000 patients spanning a range of specialities. Historically, homecare prescriptions were directly sent to the homecare company by clinicians and hospital pharmacy received payment invoices. In response to published professional standards for homecare1, the hospital pharmacy clinical screening process was introduced to ensure the safe use of medicines and to reduce wastage. Aim To evaluate the impact on pharmacy clinical screening on the homecare prescription service by: Identifying query types and measuring the error rate; and, measuring query resolution times and the delay in prescription processing. Methods The data collection was conducted over a 6-month period commencing November 2021 at a teaching NHS Trust. The sample included 100% of homecare prescriptions received by the hospital pharmacy department. Pharmacy technicians involved in the processing of payment invoices recorded the number of received prescriptions. During the clinical screening process, pharmacists involved in the identification of queries or errors relating to homecare prescription documented the presenting issue, any action taken, and the outcome on a purposefully created data collection form. The data was entered into Excel and analysed descriptively. This service evaluation did not require ethical approval. Results In total, 4,580 homecare prescriptions were clinically screened by the pharmacy team. Most prescriptions had no issues; 2.5% (n=114) had a query raised. Of these queries, 47% (n=54) necessitated clarification from prescribers without subsequent prescription amendments; 14% (n=16) required new blood tests; 13% (n=15) required prescription amendments; 8% (n=9) resulted in prescriptions being returned and not reissued; and 18% (n=20) had no documented outcome. A lack of recent in-range blood test results accounted for 39% (n=45) of queries. Data were collected during the Covid-19 pandemic, potentially impacting on patients’ ability to obtain blood tests every 3-6 months, depending on indication, to comply with Trust policy.2 Dosage enquiries accounted for 26% (n=30) of queries; most arose from discrepancies between the prescription and the most recent clinic letter. The prescribing error rate was low: 1% (n=40) of prescriptions had an error identified during the evaluation. Time from clinical screening to resolution of the raised issue was documented on 82% of (n=93) forms. Of these queries, 50% (n=46) were resolved within 3 working days, 45% (n=42) took up to 14 days, and 5% (n=5) over 14 days. Discussion/Conclusion The introduction of hospital pharmacy clinical screening of homecare prescriptions reduced prescription errors and increased safety of the service by ensuring patients had required monitoring and appropriate medicine doses. However, the project identified that clinical screening added additional processing time for those prescriptions with discrepancies, therefore potentially leading to delays in patients receiving their medications. Further work is planned to improve clarity of clinical letters and create a more robust process in achieving timely query resolutions. The main strength of the project was the relatively large sample size and prolonged data collection period. Limitations included accuracy of the recorded data on the enquiry forms for data analysis.

The burden of city's pain treatment – A longitudinal one year study of two cities via wastewater-based epidemiology

This paper explores Wastewater-Based Epidemiology (WBE) as a tool enabling understanding of city's pain treatment in an intercity longitudinal study. An intensive 13-month monitoring programme was undertaken in two adjacent urban areas in South-West England: a small commuter town Keynsham and the city of Bath (>180 samples collected). The study has shown a great potential of using triangulated WBE and National health Service (NHS) prescription data in understanding pain treatment in two contrasting communities with strong apparent seasonal patterns of short pain medications vs chronic pain treatment as well as the type of treatment used (e.g. oral vs topical). Community-wide usage of Non-Steroidal Anti-inflammatory Drugs (NSAIDs) and paracetamol in the intercity study is population size and season driven with the highest usage recorded in winter months. This contrasts with other pain pharmaceuticals, especially those used for chronic pain, where no/limited seasonal usage was recorded. Unmetabolized NSAIDs are, to a large extent, directly disposed of into the sewerage system bypassing metabolism due to their topical application. This is particularly apparent in winter months with naproxen showing the highest seasonal variability. Pharma/met (ratio of pharmaceutical and its metabolite concentration) analysis allows for tracking topical (non-metabolic) application/down-the-drain disposal of pharmaceuticals with frequent instances of direct disposal of NSAIDs into the sewerage system observed. Normalisation of pharma markers to population size shows comparable estimates of pharma usage in the two cities confirming population as the main driver of pharma loads in wastewater. Variable application patterns of pain pharmaceuticals make back-calculation of intake more convoluted. Intake calculated using percentage excretion of parent NSAIDs will likely lead to overestimation, as it is assumed that NSAIDs are subject to extensive metabolism (this is not the case for topical applications). Intake calculated using percentage excretion of metabolites (or parent compound) as consumption markers leads to underestimation of NSAIDs usage due to contributions from topical application not being accounted for. Prescription data indicates cumulative internal and topical usage, but the data ignores large proportion of over-the-counter usage. Therefore, we have proposed a combined approach allowing for estimation of total usage including, and differentiating between, topical application and oral administration.

P092Measuring utilization of mifepristone in medication management of missed abortions: Retrospective claims analysis study

<h3>Objectives</h3> Characterize the use of mifepristone with misoprostol for the medical management of missed abortion in the US. <h3>Methods</h3> We conducted a retrospective cohort study utilizing IBM MarketScan® employer-sponsored healthcare claims database between January 1, 2016 and December 31, 2019. We identified a cohort of women aged 14–54 undergoing medical management of missed abortion using ICD-10 codes from outpatient service codes and prescription claims. We used prescription claims to identify utilization of monotherapy (misoprostol alone) or combination therapy (mifepristone and misoprostol). Our primary outcome was the proportion of missed abortions managed medically using combination therapy. We employed logistic regression to assess the association of the primary outcome with geographic region and a binary categorical variable for whether the prescription was filled before or after the American College of Obstetricians and Gynecologists (ACOG) updated guidelines to recommend the use of combination therapy. <h3>Results</h3> There were 20,508 cases of medically managed missed abortion included in the cohort. Combination therapy was used in 0.7% (n=141) while 99.3% (n=20,367) were treated with monotherapy. In multivariable analysis, receiving treatment after the ACOG guideline update (OR, 2.22; CI, 1.58–3.13) and in the West (OR, 8.62, CI, 4.69–15.81) or Northeast (OR, 15.29; CI, 8.46–27.65) were associated with increased odds of receiving combination therapy. <h3>Conclusions</h3> Very few women in our cohort received the more efficacious combination therapy. The availability of mifepristone is likely a barrier to routine utilization. Efforts to increase the use of combination therapy are needed.

REVIEW: FACTORS AFFECTING WAITING TIME FOR OUTPATIENT PRESCRIPTION DRUGS IN HOSPITALS

Waiting is an activity which frequently causes uncomfortable feelings, particularly in health services. Patients who attend to health care facilities such as hospitals, are eager to receive good and quality health care system without having to wait for a long time. The quality of pharmaceutical services in hospitals influences the level of patient satisfaction with the services provided by pharmacy staff in drug services to patients. There are still numerous waiting times for outpatient prescription drug services in Indonesian hospitals which do not fulfill minimum service standards. Thus, the objective of this review articles is to determine the factors affecting the waiting time for outpatient prescription services at the hospital. This review was conducted by employing the literature review method with a sample size of 12 articles. The results acquired are several factors influencing the waiting time for outpatient drugs in hospitals encompassing: receiving prescriptions, providing etiquette, working on prescription drug concoctions, submitting drugs, facilities and infrastructure, human resources, hospital management information systems and standard operating procedures. Based on the complexity of the issue which was found in this review, the most dominant and influencing factors on the waiting time of outpatient drugs at the hospital are prescription reception, providing etiquette, preparation of prescription drugs, and submitting drugs.

Shared Decision Making and Peer Support: New Directions for Research and Practice.

Shared Decision Making and Peer Support: New Directions for Research and Practice.

Faktor yang Memengaruhi Waktu Tunggu Pelayanan Resep Rawat Jalan di Instalasi Farmasi Rumah Sakit: Sistematik Review

Pharmacy services are one of the services that must be minimal in a hospital. One indicator to measure pharmaceutical services that meet standards is the waiting time for services, especially prescription drugs. Waiting time for services is one of the most important concerns because it affects patient satisfaction. The reality is that there are still waiting times for prescription drugs that do not meet the minimum service standards in hospitals. This research aims to determine the factors that influence waiting times for outpatient prescription services in hospital pharmacy installations. This study uses a descriptive approach. This study uses a systematic review. Several factors influence the waiting time for prescription drug services in hospital pharmacy installations, namely the lack of human resources in pharmaceutical installations, the completeness of patient files that have not been fulfilled, the lack of availability of drugs prescribed by doctors, the use of electronic and manual prescriptions together, the number of prescription doctors not in National Forum, the number of prescriptions that ask for concoction drugs, information systems in pharmaceutical installations that are less than optimal, doctors who are difficult to contact when prescriptions are difficult to read, space is inadequate. Hospitals need to pay attention to these factors so that they can maintain the quality of hospital services.

Psychotropic Prescriptions During the COVID-19 Pandemic Among U.S. Children and Adolescents Receiving Mental Health Services.

Objective: Increased mental health problems among children and adolescents during the COVID-19 pandemic may have impacted psychotropic medication use. This study describes trends in monthly psychotropic medications before and early in the COVID-19 pandemic among 2- to 17-year-old children and adolescents with mental health disorders. Methods: A cross-sectional study design using the 2019-2020 IQVIA™ prescription and medical commercial claims data to estimate the proportion of children and adolescents with any psychotropic prescription in the month out of all with any mental health-related medical or prescription services in the month and the year-over-year percent change. We assessed monthly proportions of youth who filled a psychotropic prescription overall and by psychotropic class, stratified by age and gender. Results: Of the 8,896,713 children and adolescents in the sample, 24.7% received psychotropic medication during the study period. The proportion of the cohort prescribed a psychotropic medication in a given month averaged 27%-28% from January 2019 to February 2020, peaked at 36.9% in April 2020, and gradually declined to 28.7% in September 2020. The largest year-over-year percent change was in April for antipsychotic (41.9%) and antidepressant (37.9%) medication, which remained higher in September 2020 compared to September 2019, particularly among ages 6 years or older and females. Conclusion: The proportion of youth with a psychotropic prescription increased at the onset of the COVID-19 pandemic, later returning to prepandemic levels. However, antipsychotics and antidepressants remained higher than prepandemic, highlighting the need to further understand the long-lasting effects of the pandemic on children and adolescents.

Age-Related Variation in the Provision of Primary Care Services and Medication Prescriptions for Patients with Cardiovascular Disease.

As population aging progresses, demands of patients with cardiovascular diseases (CVD) on the primary care services is inevitably increased. However, the utilisation of primary care services across varying age groups is unknown. The study aims to explore age-related variations in provision of chronic disease management plans, mental health care, guideline-indicated cardiovascular medications and influenza vaccination among patients with CVD over differing ages presenting to primary care. Data for patients with CVD were extracted from 50 Australian general practices. Logistic regression, accounting for covariates and clustering effects by practices, was used for statistical analysis. Of the 14,602 patients with CVD (mean age, 72.5 years), patients aged 65–74, 75–84 and ≥85 years were significantly more likely to have a GP management plan prepared (adjusted odds ratio (aOR): 1.6, 1.88 and 1.55, respectively, p < 0.05), have a formal team care arrangement (aOR: 1.49, 1.8, 1.65, respectively, p < 0.05) and have a review of either (aOR: 1.63, 2.09, 1.93, respectively, p < 0.05) than those < 65 years. Patients aged ≥ 65 years were more likely to be prescribed blood-pressure-lowering medications and to be vaccinated for influenza. However, the adjusted odds of being prescribed lipid-lowering and antiplatelet medications and receiving mental health care were significantly lowest among patients ≥ 85 years. There are age-related variations in provision of primary care services and pharmacological therapy. GPs are targeting care plans to older people who are more likely to have long-term conditions and complex needs.

Incorporating medication therapy management into community pharmacy workflows.

Medication Therapy Management (MTM) is a group of pharmacist-provided services that optimize individual patients' drug therapy outcomes. Since community pharmacies' primary business platform is the dispensing of medications, and providing MTM services is a secondary source of revenue, pharmacies with limited resources are operationally challenged when trying to efficiently deliver both types of services. To address this problem, we follow a queueing network approach to develop an operational model of a community pharmacy workflow. Through our model, we derive structural results to determine conditions for a pharmacy to achieve economies of scope when providing both prescription and MTM services. We also develop a process simulation to compare different scenarios according to our economies of scope model, varying in provided services, personnel, service demand, and other operational variables. Outcomes examined include profitability, service rate, and sensitivity of some operation variables to profitability. Based on our results, we provide practical insights to help community pharmacy administrators and healthcare policy makers in their decision process.

Can Redesign SOP Oriented Time Standardization and Authorization According to Job Description to Waiting Time be a Solution?

Pharmacy installation is part of the service system that influences hospital quality standards, one of which is waiting time for pharmaceutical service. The waiting time at the Outpatient Pharmacy Installation of Hospital X exceeds the Hospital Minimum Service Standard and Hospital Quality Indicators, which is 50 minutes. This study aims to determine the root of the problem and the solution to the long waiting time for prescription drug services at Outpatient Pharmacy installations. This research is a case study with a search method for identifying the root of the problem, determining alternative solutions, and prioritizing the main solution. The long waiting time for finished drug services is caused by the lack of shifts of workers when poly peak times, the absence of flow information and appropriate SOPs when pharmaceutical prescription services run concurrently, and non-compliance by pharmacists with SOPs for pharmaceutical services. The main solution was to create flow information and a new SOP for outpatient prescription services.

Digital Transformation &amp; COVID-19: the Case of Greece

The impact of the COVID-19 pandemic has caused significant problems to many different public sector functions worldwide extending further than just public health. To protect citizens and keep services functional, the digital transformation of the public sector was selected by many countries as the most reliable solution, a policy with the goal of servicing citizens on time and efficiently. Following the examples of other countries, Greece also moved in the same direction, successfully managing to respond to the strict demand times and implement many digital services such as Gov. gr, a central platform for public administration information and services, the digital platform myDeskLive.gov.gr for remotely serving citizens and businesses by conducting digital appointments and the creation of the Paperless Prescription Service. These are prime examples of how successful this transition has been for Greece, considering how far behind it was lagging compared to other advanced countries, and the progress made in such a short period of time. This paper presents in detail the innovative applications implemented by Greece in the context of combating and limiting the effects of the COVID-19 pandemic supported by statistics that reflect the spread use of these applications.

Optometry independent prescribing during COVID lockdown in Wales

IntroductionDuring the COVID‐19 lockdown, primary care optometry services in Wales moved to a hub model of provision. Three independent prescribing models were available in different areas: a commissioned Independent Prescribing Optometry Service (IPOS), independent prescribers that were not commissioned and no independent prescribers available. This allowed a unique opportunity for comparison.MethodOptometry practices completed an online survey for each patient episode. Analysis of the data gave insight into patient presentation to urgent eye services and the drugs prescribed by optometrists. Medicines prescribed, sold or given and onward referral were compared between areas with an IPOS service (n = 2), those with prescribers but no commissioned service (n = 2) and those with no prescribers (n = 2).ResultsData from 22,434 reported patient episodes from 81 optometry practices in six health boards between 14 April 2020 and 30 June 2020 were analysed. Urgent care accounted for 10,997 (49.02%) first appointments and 1777 (7.92%) follow‐ups. Most (18,006, 80.26%) patients self‐referred. The most common presenting symptom was ‘Eye pain/discomfort’ (4818, 43.81% of urgent attendances). Anterior segment pathology was the most reported finding at first (6078, 55.27%) and follow‐up (1316, 74.06%) urgent care appointments. Topical steroids (373, 25.99% of prescriptions) were the most prescribed medications. More medications were prescribed in areas with an IPOS service (1136, 79.16% of prescriptions) than areas with prescribers but no commissioned service. There were more follow‐up appointments in optometric practice and fewer urgent referrals to ophthalmology in IPOS areas.ConclusionUrgent care services were most utilised by patients with discomfort caused by anterior eye conditions. IPOS services enabled optometrists to manage conditions to resolution without referral and without reduction in medications sold or given. Commissioners should recognise the value in reducing burden in urgent ophthalmology and the need for follow‐up as part of a commissioned independent prescribing service.

Analysis of the Correlation Between Waiting Time for Prescription Services and Patient Satisfaction in Puskesmas

 Efforts to improve and control the quality of pharmaceutical services to ensure patient satisfaction are carried out by evaluating the waiting time for prescription services in preparing pharmaceutical preparations and the level of patient satisfaction in pharmaceutical services [1]. Puskesmas is the first level health facility that participates in efforts to achieve the target of Minimum Service Standards [2]. The purpose of this study was to analyze the relationship between waiting time for prescription services and the level of patient satisfaction at the Puskesmas. This study used an observational research design with a design approach cross sectional. Determination of the research sample using a purposive sampling method. Analysis of the data used for this research is univariate analysis and bivariate analysis, as well as statistical chi-square test.Results: This study used an observational research design with a cross sectional design approach. Analysis of the data used for this study using the SPSS program, as well as the chi-square statistical test.              According to standard waiting time for prescription service, 155 recipes (92.90%) were categorized according to standard and 11 prescriptions (7.10%) were not according to standard. The level of satisfaction of respondents was categorized as satisfied as many as 132 respondents (85.16%) while those who felt dissatisfied were 23 respondents (14.84%). From the results of the analysis of the chi-square test waiting time and the level of patient satisfaction obtained P Value &lt;0.05.There is a relationship between waiting time for prescription services and the level of patient satisfaction at the Puskesmas.Â

More than signposting: Findings from an evaluation of a social prescribing service.

This paper presents findings from an evaluation of a social prescribing service, undertaken between January 2019 and December 2020. Data was collected through interviews and focus groups with a range of groups including social prescribing managers, link workers (LWs), referrers (GPs and social work practitioners), clients, Voluntary and Community Sector (VCS) agencies and groups. Thematic analysis of data was undertaken, and findings were presented in respect of clients' journeys into social prescribing; the support received from LWs; their onward journeys to VCS support. The findings highlight the challenges for individuals in contacting new agencies/groups and the importance of practitioner referral into and onwards from social prescribing, as well as buddying to support clients on initial agency visits. The depth of the LW role is highlighted, as well as the complexity of client circumstances, highlighting a need for 'more than signposting', and challenging the notion of self-referral as an indicator of motivation. Social prescribing has been positioned as amongst the solutions to the challenges of primary care. However, referrals from GPs were low and significantly outnumbered by those from social workers; this suggests a need to explore in greater depth the use of social prescribing by social workers, who have, to date, been absent from social prescribing research.

Gambaran Pengobatan Pasien Terkonfirmasi Covid-19 yang Melakukan Isolasi Mandiri di Rumah

Covid-19 (Coronavirus Disease -19) pandemic is still a health problem for Indonesia and even the world. The limitations of health facilities such as hospitals in treating Covid-19 patients require Covid-19 patients with mild to moderate symptoms to self-quarantine/isolate at home. This study was conducted to see the description of treatment for confirmed Covid-19 patients who are self-isolating at home. The descriptive method was used in this study by purposive random sampling of confirmed Covid-19 patients who were self-isolating at home by filling out a questionnaire from a google form. The previous questionnaire had gone through the content validity stage by professional health workers, pharmacists, nurses and doctors. The data obtained were processed and analyzed in a qualitative descriptive manner based on the guidelines for the treatment of patients confirmed positive for COVID-19 from the Ministry of Health of the Republic of Indonesia and WHO (World Health Organization). This study displays data that there are 52 Covid-19 respondents who self-isolate at home, 75% receive doctor's prescription services and 25% without a doctor's prescription. The use of drugs on a doctor's prescription is in accordance with the Covid-19 therapeutic management from the Ministry of Health with the therapy given in the form of azithromycin, oseltamivir, vitamin C, vitamin D, and symptomatic therapy. While the use of drugs without a doctor's prescription, 8% use hard drugs without a doctor's prescription, while 92% of respondents use over-the-counter and limited-free drugs to treat symptoms and complaints. The treatment of Covid-19 patients who are self-isolating at home, whether with a doctor's prescription or not, is in accordance with the Covid-19 management guidelines from the Ministry of Health.

The Impact of Multiple Long-Term Care Services Use on Dementia and Nondementia Caregivers' Health Care Utilization and Costs.

The study examined the effects of multiple long-term care (LTC) services (i.e., using both social and professional care services) on caregivers of service recipients with and without dementia. We retrieved data for 10,771 caregivers of older adults in the Ten-Year Long-Term Care Project (TLTCP) in Taiwan. We examined the effects of care recipients' initial prescription of single or multiple LTC services on their caregivers' healthcare services use, including outpatient, emergency department (ED), and inpatient services. For care recipients prescribed a single LTC service, dementia caregivers had 0.82 more ED visits and 10.4% higher total fees than nondementia caregivers (p < .05). However, for care recipients prescribed multiple LTC services, dementia caregivers and nondementia caregivers used healthcare services at similar levels, and dementia caregivers had 3.5% lower per-visit outpatient fees (p < .05). Providing multiple LTC services for people with dementia results in great benefit to their caregivers.

EVALUASI WAKTU TUNGGU RESEP OBAT TERHADAP KEPUASAN PASIEN RAWAT JALAN DI INSTALASI FARMASI RUMAH SAKIT ASSYIFA KOTA TANGERANG

ABSTRACTHospital is an important health service center and is needed to meet health needs. This study aims to evaluate the waiting time for prescription non-concoction and concoction medicines based on the hospital's minimum service standards and their effect on general outpatient satisfaction at the Pharmacy Installation of RSIA Assyifa, Tangerang. This study used a descriptive research design of outpatients who redeemed non-concoction and concoction medicines. Calculation of the waiting time for prescription services for non-concoction and concoction medicine is using a digital clock. Satisfaction was measured using a questionnaire which was analyzed multivariate. The samples taken in the study were 222 respondents. The results showed that the average waiting time for prescription of non-concoction medicine (8.9 minutes) and concoction medicine (16.6 minutes) had met the standards set by the hospital's SPM in the pharmaceutical sector according to the Minister of Health of the Republic of Indonesia NO. 129 of 2008 and by RSIA Assyifa. The results in the multivariate analysis obtained t = 10.126 and the standard coefficient of 0.88, indicating that waiting time has a strong positive effect on patient satisfaction with prescription of non-concoction and concoction medicine services at RSIA Assyifa.Keywords: patient satisfaction, prescription service, waiting time

Prevalence and patterns of anti-osteoporotic drug use based on 2019 real-world nationwide data in Greece.

Based on the 2019 European scorecard (SCOPE), osteoporosis is diagnosed in an estimated 683,679 individuals in Greece, with the direct cost of incident fractures being €694.7 million, although further relevant real-world data are scarce. The e-Government Center for Social Security Services prescription database, which covers almost 100% of the Greek population, was used to capture all individuals on anti-osteoporotic treatment during 2019. A total of 288,983 among 8,641,341 people, corresponding to 3.3% of the total adult Greek population, had filled at least one anti-osteoporotic prescription (6.0% and 0.36% for females and males, respectively). Prevalence of anti-osteoporotic treatment increased with age, from 0.15% in those younger than 50 to 8.6% in those older than 70years. Oral bisphosphonates were more frequently prescribed (58.8%), followed by denosumab (39.4%). Alendronate was more frequently prescribed in males and in people younger than 60years. Denosumab was more frequently prescribed in females and in people older than 60years. Selective estrogen-receptor modulators, teriparatide, and parenteral bisphosphonates accounted for 1.1%, 1.0%, and 0.02% of all prescriptions, respectively. Orthopedic surgeons (39.6%), endocrinologists (19.6%), general practitioners (19%), and rheumatologists (9.3%) prescribed the vast majority of anti-osteoporotic regimens, with significant differences in prescription patterns. The annual cost of treatment per patient increased significantly with age, being on average €323.33. Less than half of the estimated number of individuals with osteoporosis in 2019 in Greece received treatment, with the total annual cost being far less than the estimated cost of incident-fragility fractures. The impact of this undertreatment on related health care costs merits further investigation.